Jingkun Yi

5PUBLICATIONS
10CO-AUTHORS
Tissue engineeringInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)International and development communicationMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
TAL1 is indispensable in ETV2-primed human endothelial cell fate determination.

|Oct 01, 2025
A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment.

Jingkun Yi, Meng Xu, Ling Han

|Jul 13, 2024
Inhibition of Indoleamine 2,3-Dioxygenase Exerts Antidepressant-like Effects through Distinct Pathways in Prelimbic and Infralimbic Cortices in Rats under Intracerebroventricular Injection with Streptozotocin.

Yu Qin, Xiao Hu, Hui-Ling Zhao

|Jun 28, 2023
IntiCom-DB: A Manually Curated Database of Inter-Tissue Communication Molecules and Their Communication Routes.

Changxian Xiong, Yiran Zhou, Yu Han

|Nov 11, 2022
Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation.

Jingkun Yi, Rucong Liu, Yu Liu

Pageof 1

Frequent Collaborators

1 joint publications

Ruimao Zheng

1 joint publications

Xiaobo Yu

1 joint publications

Yun Zhao

1 joint publications

Mengze Sun